Silas Inman - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Silas Inman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Silas Inman
Verified
Senior Vice President, Content, CURE Magazine
New York
Beats
Politics, economics, medical news
Content
By Silas Inman Verified| Managed Healthcare Executive Verified Glucagon-like peptide 1 (GLP-1) treatment resulted in side effects that often required additional medications, increasing overall pharmacy use and costs among GLP-1 drugs compared with nonusers, according to a real-world claims analysis completed by Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence (BHI) that was presented as a poster at the annual meeting of the Academy of Managed Care Pharmacy in Houston this week When excluding the costs of the GLP-1 drugs themselves,...
Multiple Myeloma Treatment Is a Success Story. The Price Is Complex Treatment Decisions - and Cost | AMCP Annual 2025
By Silas Inman Verified| Managed Healthcare Executive Verified The most used words to describe the treatment paradigm for patients with multiple myeloma were complicated and complex, according to a poll during a session on managing multiple myeloma at the annual meeting of the Academy of Managed Care Pharmacy (AMCP) in Houston. The complexity comes from a wealth of highly effective, multidrug regimens that have gained FDA approval in a relatively short amount of time.
By Silas Inman Verified| Managed Healthcare Executive Verified Glucagon-like peptide 1 (GLP-1) treatment resulted in side effects that often required additional medications, increasing overall pharmacy use and costs among GLP-1 drugs compared with nonusers, according to a real-world claims analysis completed by Blue Cross Blue Shield Association (BCBSA) and Blue Health Intelligence (BHI) that was presented as a poster at the annual meeting of the Academy of Managed Care Pharmacy in Houston this week When excluding the costs of the GLP-1 drugs themselves,...
Company Info
CURE Magazine
Curetoday.com and CURE magazine, our free publication, are the leading resources for patients with cancer, survivors and their caregivers to become empowered advocates in their journeys. We deliver cancer updates, research and education to help make cancer understandable during every stage of the experience and connect the cancer community.
'+1 609-716-7777
Founded: 2002